The Effects of Specific tDCS on Cognition in MCI

Recruiting N/A Interventional Study
Alzheimer Disease Parkinson Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
45 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
120 (estimated)
Sponsor
Istanbul Medipol University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
INTRODUCTION: Mild cognitive impairment (MCI) is a critical transitional stage in dementia related disorders. Dorsolateral prefrontal cortex (DLPFC), and the lateral parietal (LPC) cortex are subjected to neuropathological changes in MCI. Parietal memory network (PMN) integrity alterations and default mode network (DMN) alterations also occur in MCI. Transcranial direct current stimulation (tDCS)…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Providing an informed consent; 2. Literate and between 45-80 years of age; 3. 60 females and 60 males; 4. Diagnosed with PD based on criteria suggested by UK Parkinson's Disease Society, Brain Bank and PD-MCI in accordance with the diagnostic criteria suggestions by Litvan; 5…
Contacts

Burak Yuluğ, Prof. DR. MD

+90 242 510 6135

burakyulug@gmail.com

CONTACT

Cennet Sena Parlatan, PhD Cand

+90 507 779 91 64

cennetsenaparlatan@gmail.com

CONTACT